The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
The genetic epidemiology of prostate cancer and its clinical implications
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Finding the missing heritability of complex diseases
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336
An integrated map of genetic variation from 1,092 human genomes
The 1000 Genomes Project Consortium (2012) · Nature · doi:10.1038/nature11632 · Cited by 7,711
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A., & Hemminki, K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007133430201 · Cited by 4,114
Screening and Prostate-Cancer Mortality in a Randomized European Study
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Ciatto, S., Nelen, V., Kwiatkowski, M., Lujan, M., Lilja, H., Zappa, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810084 · Cited by 4,014
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Andriole, G. L., Crawford, E. D., Grubb, R. L., Buys, S. S., Chia, D., Church, T. R., Fouad, M. N., Gelmann, E. P., Kvale, P. A., Reding, D. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810696 · Cited by 2,906
Cancer Risks in BRCA2 Mutation Carriers
Breast Cancer Linkage Consortium, T. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.15.1310 · Cited by 1,527
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
Yeager, M., Orr, N., Hayes, R. B., Jacobs, K. B., Kraft, P., Wacholder, S., Minichiello, M. J., Fearnhead, P., Yu, K., Chatterjee, N., et al. (2007) · Nature Genetics · doi:10.1038/ng2022 · Cited by 1,122
Andriole, G. L., Crawford, E. D., Grubb, R. L., Buys, S. S., Chia, D., Church, T. R., Fouad, M. N., Isaacs, C., Kvale, P. A., Reding, D. J., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr500 · Cited by 1,121
Bentzen, S. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1950 · Cited by 1,096
Systematic Population-Based Assessment of Cancer Risk in First-Degree Relatives of Cancer Probands
Goldgar, D. E., Easton, D. F., Cannon-Albright, L. A., & Skolnick, M. H. (1994) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/86.21.1600 · Cited by 1,031
Self-citationFong, P. C., Yap, T. A., Boss, D. S., Carden, C. P., Mergui-Roelvink, M., Gourley, C., De Greve, J., Lubinski, J., Shanley, S., Messiou, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.9589 · Cited by 1,010
Wilkinson, E. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00737-4 · Cited by 951
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial
Hugosson, J., Carlsson, S., Aus, G., Bergdahl, S., Khatami, A., Lodding, P., Pihl, C.-G., Stranne, J., Holmberg, E., & Lilja, H. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70146-7 · Cited by 936
Multiple loci identified in a genome-wide association study of prostate cancer
Thomas, G., Jacobs, K. B., Yeager, M., Kraft, P., Wacholder, S., Orr, N., Yu, K., Chatterjee, N., Welch, R., Hutchinson, A., et al. (2008) · Nature Genetics · doi:10.1038/ng.91 · Cited by 900
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24
Gudmundsson, J., Sulem, P., Manolescu, A., Amundadottir, L. T., Gudbjartsson, D., Helgason, A., Rafnar, T., Bergthorsson, J. T., Agnarsson, B. A., Baker, A., et al. (2007) · Nature Genetics · doi:10.1038/ng1999 · Cited by 864
Castro, E., Goh, C., Olmos, D., Saunders, E., Leongamornlert, D., Tymrakiewicz, M., Mahmud, N., Dadaev, T., Govindasami, K., Guy, M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.1882 · Cited by 850
Self-citationMultiple newly identified loci associated with prostate cancer susceptibility
Collaborators, T. U. G. P. C. S., Eeles, R. A., British Association of Urological Surgeons' Section of Oncology, Collaborators, T. U. P. S., Kote-Jarai, Z., Giles, G. G., Olama, A. A. A., Guy, M., Jugurnauth, S. K., Mulholland, S., et al. (2008) · Nature Genetics · doi:10.1038/ng.90 · Cited by 844
Self-citationA common variant associated with prostate cancer in European and African populations
Amundadottir, L. T., Sulem, P., Gudmundsson, J., Helgason, A., Baker, A., Agnarsson, B. A., Sigurdsson, A., Benediktsdottir, K. R., Cazier, J.-B., Sainz, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1808 · Cited by 787
Mendelian inheritance of familial prostate cancer.
Carter, B. S., Beaty, T. H., Steinberg, G. D., Childs, B., & Walsh, P. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3367 · Cited by 781
Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype
Barnett, G. C., West, C. M. L., Dunning, A. M., Elliott, R. M., Coles, C. E., Pharoah, P. D. P., & Burnet, N. G. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2587 · Cited by 771
Gudmundsson, J., Sulem, P., Steinthorsdottir, V., Bergthorsson, J. T., Thorleifsson, G., Manolescu, A., Rafnar, T., Gudbjartsson, D., Agnarsson, B. A., Baker, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2062 · Cited by 723
Evidence for a prostate cancer susceptibility locus on the X chromosome.
Xu, J., Meyers, D., Freije, D., Isaacs, S., Wiley, K., Nusskern, D., Ewing, C., Wilkens, E., Bujnovszky, P., Bova, G. S., et al. (1998) · Nature Genetics · doi:10.1038/2477 · Cited by 690
Germline Mutations in HOXB13 and Prostate-Cancer Risk
Ewing, C. M., Ray, A. M., Lange, E. M., Zuhlke, K. A., Robbins, C. M., Tembe, W. D., Wiley, K. E., Isaacs, S. D., Johng, D., Wang, Y., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110000 · Cited by 658
Cumulative Association of Five Genetic Variants with Prostate Cancer
Zheng, S. L., Sun, J., Wiklund, F., Smith, S., Stattin, P., Li, G., Adami, H.-O., Hsu, F.-C., Zhu, Y., Bälter, K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa075819 · Cited by 631
Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men
Freedman, M. L., Haiman, C. A., Patterson, N., McDonald, G. J., Tandon, A., Waliszewska, A., Penney, K., Steen, R. G., Ardlie, K., John, E. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605832103 · Cited by 612
Spencer, C. C. A., Su, Z., Donnelly, P., & Marchini, J. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000477 · Cited by 605
Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force
Chou, R., Croswell, J. M., Dana, T., Bougatsos, C., Blazina, I., Fu, R., Gleitsmann, K., Koenig, H. C., Lam, C., Maltz, A., et al. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-11-201112060-00375 · Cited by 573
Sandhu, S. K., Schelman, W. R., Wilding, G., Moreno, V., Baird, R. D., Miranda, S., Hylands, L., Riisnaes, R., Forster, M., Omlin, A., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70240-7 · Cited by 562
A candidate prostate cancer susceptibility gene at chromosome 17p
Tavtigian, S. V., Simard, J., Teng, D. H. F., Abtin, V., Baumgard, M., Beck, A., Camp, N. J., Carillo, A. R., Chen, Y., Dayananth, P., et al. (2001) · Nature Genetics · doi:10.1038/84808 · Cited by 557
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
Initiative, T. C. R. U. G. (. O. G.-O., Eeles, R. A., Bioresource, T. A. P. C., The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology, Collaborators, T. U. P. (. T. F. C. A. T. S., The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, Olama, A. A. A., Benlloch, S., Saunders, E. J., Leongamornlert, D. A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2560 · Cited by 542
Self-citationVariation in Cancer Risks, by Mutation Position, in BRCA2 Mutation Carriers
Thompson, D., & Easton, D. (2001) · The American Journal of Human Genetics · doi:10.1086/318181 · Cited by 489
Self-citationA recurrent mutation in PALB2 in Finnish cancer families
Erkko, H., Xia, B., Nikkilä, J., Schleutker, J., Syrjäkoski, K., Mannermaa, A., Kallioniemi, A., Pylkäs, K., Karppinen, S.-M., Rapakko, K., et al. (2007) · Nature · doi:10.1038/nature05609 · Cited by 466
Principles for the post-GWAS functional characterization of cancer risk loci
Freedman, M. L., Monteiro, A. N. A., Gayther, S. A., Coetzee, G. A., Risch, A., Plass, C., Casey, G., De Biasi, M., Carlson, C., Duggan, D., et al. (2011) · Nature Genetics · doi:10.1038/ng.840 · Cited by 438
The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology, Eeles, R. A., Collaborators, T. U. P. S., The PRACTICAL Consortium, Kote-Jarai, Z., Al Olama, A. A., Giles, G. G., Guy, M., Severi, G., Muir, K., et al. (2009) · Nature Genetics · doi:10.1038/ng.450 · Cited by 418
Self-citationEvaluating coverage of genome-wide association studies
Barrett, J. C., & Cardon, L. R. (2006) · Nature Genetics · doi:10.1038/ng1801 · Cited by 415
Collaborators, T. U., Kote-Jarai, Z., Leongamornlert, D., Saunders, E., Tymrakiewicz, M., Castro, E., Mahmud, N., Guy, M., Edwards, S., O'Brien, L., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.383 · Cited by 399
Self-citationCommon sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer
Gudmundsson, J., Sulem, P., Rafnar, T., Bergthorsson, J. T., Manolescu, A., Gudbjartsson, D., Agnarsson, B. A., Sigurdsson, A., Benediktsdottir, K. R., Blondal, T., et al. (2008) · Nature Genetics · doi:10.1038/ng.89 · Cited by 370
The multiethnic cohort study: exploring genes, lifestyle and cancer risk
Kolonel, L. N., Altshuler, D., & Henderson, B. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1389 · Cited by 367
Predisposing Gene for Early-Onset Prostate Cancer, Localized on Chromosome 1q42.2-43
Berthon, P., Valeri, A., Cohen-Akenine, A., Drelon, E., Paiss, T., Wöhr, G., Latil, A., Millasseau, P., Mellah, I., Cohen, N., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301879 · Cited by 362
Gudmundsson, J., Sulem, P., Gudbjartsson, D. F., Blondal, T., Gylfason, A., Agnarsson, B. A., Benediktsdottir, K. R., Magnusdottir, D. N., Orlygsdottir, G., Jakobsdottir, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.448 · Cited by 352
Ahmadiyeh, N., Pomerantz, M. M., Grisanzio, C., Herman, P., Jia, L., Almendro, V., He, H. H., Brown, M., Liu, X. S., Davis, M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910668107 · Cited by 336
Evidence for a Rare Prostate Cancer–Susceptibility Locus at Chromosome 1p36
Gibbs, M., Stanford, J. L., McIndoe, R. A., Jarvik, G. P., Kolb, S., Goode, E. L., Chakrabarti, L., Schuster, E. F., Buckley, V. A., Miller, E. L., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302287 · Cited by 322
Germline BRCA1 mutations increase prostate cancer risk
Collaborators, T. U., Leongamornlert, D., Mahmud, N., Tymrakiewicz, M., Saunders, E., Dadaev, T., Castro, E., Goh, C., Govindasami, K., Guy, M., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.146 · Cited by 302
Self-citationMultiple loci on 8q24 associated with prostate cancer susceptibility
The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology, Al Olama, A. A., Collaborators, T. U. P. T. F. C. A. T. S. (. S., Kote-Jarai, Z., Giles, G. G., Guy, M., Morrison, J., Severi, G., Leongamornlert, D. A., Tymrakiewicz, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.452 · Cited by 295
Self-citationSeven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study
The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology, Kote-Jarai, Z., The UK ProtecT Study Collaborators, T. A. P. C. B., The PRACTICAL Consortium, Olama, A. A. A., Giles, G. G., Severi, G., Schleutker, J., Weischer, M., Campa, D., et al. (2011) · Nature Genetics · doi:10.1038/ng.882 · Cited by 289
Self-citationTakata, R., Akamatsu, S., Kubo, M., Takahashi, A., Hosono, N., Kawaguchi, T., Tsunoda, T., Inazawa, J., Kamatani, N., Ogawa, O., et al. (2010) · Nature Genetics · doi:10.1038/ng.635 · Cited by 283
Schröder, F. H., Hugosson, J., Carlsson, S., Tammela, T., Määttänen, L., Auvinen, A., Kwiatkowski, M., Recker, F., & Roobol, M. J. (2012) · European Urology · doi:10.1016/j.eururo.2012.05.068 · Cited by 270
Duggan, D., Zheng, S. L., Knowlton, M., Benitez, D., Dimitrov, L., Wiklund, F., Robbins, C., Isaacs, S. D., Cheng, Y., Li, G., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm250 · Cited by 254
Evidence for a Prostate Cancer–Susceptibility Locus on Chromosome 20
Berry, R., Schroeder, J. J., French, A. J., McDonnell, S. K., Peterson, B. J., Cunningham, J. M., Thibodeau, S. N., & Schaid, D. J. (2000) · The American Journal of Human Genetics · doi:10.1086/302994 · Cited by 253
Lee, J., Demissie, K., Lu, S.-E., & Rhoads, G. G. (2007) · Cancer Control · doi:10.1177/107327480701400111 · Cited by 243
Barnett, G. C., Coles, C. E., Elliott, R. M., Baynes, C., Luccarini, C., Conroy, D., Wilkinson, J. S., Tyrer, J., Misra, V., Platte, R., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70302-3 · Cited by 240
Chi, K. N., Hotte, S. J., Yu, E. Y., Tu, D., Eigl, B. J., Tannock, I., Saad, F., North, S., Powers, J., Gleave, M. E., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.8771 · Cited by 236
Prostate Cancer Progression and Survival in BRCA2 Mutation Carriers
Tryggvadottir, L., Vidarsdottir, L., Thorgeirsson, T., Jonasson, J. G., Olafsdottir, E. J., Olafsdottir, G. H., Rafnar, T., Thorlacius, S., Jonsson, E., Eyfjord, J. E., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm005 · Cited by 231
Haiman, C. A., Chen, G. K., Blot, W. J., Strom, S. S., Berndt, S. I., Kittles, R. A., Rybicki, B. A., Isaacs, W. B., Ingles, S. A., Stanford, J. L., et al. (2011) · Nature Genetics · doi:10.1038/ng.839 · Cited by 222
International Consortium for Prostate Cancer Genetics, Xu, J., Lange, E. M., Lu, L., Zheng, S. L., Wang, Z., Thibodeau, S. N., Cannon-Albright, L. A., Teerlink, C. C., Camp, N. J., et al. (2013) · Human Genetics · doi:10.1007/s00439-012-1229-4 · Cited by 201
Self-citationNBS1 Is a Prostate Cancer Susceptibility Gene
Cybulski, C., Górski, B., Dębniak, T., Gliniewicz, B., Mierzejewski, M., Masojć, B., Jakubowska, A., Matyjasik, J., Złowocka, E., Sikorski, A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2502 · Cited by 189
Xu, J., Mo, Z., Ye, D., Wang, M., Liu, F., Jin, G., Xu, C., Wang, X., Shao, Q., Chen, Z., et al. (2012) · Nature Genetics · doi:10.1038/ng.2424 · Cited by 180
Goddard, K. A. B., Witte, J. S., Suarez, B. K., Catalona, W. J., & Olson, J. M. (2001) · The American Journal of Human Genetics · doi:10.1086/320103 · Cited by 179
Antoniou, A. C., Beesley, J., McGuffog, L., Sinilnikova, O. M., Healey, S., Neuhausen, S. L., Ding, Y. C., Rebbeck, T. R., Weitzel, J. N., Lynch, H. T., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1907 · Cited by 176
Self-citationProstate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype
Collaborators, T. I. A. E., Mitra, A., Fisher, C., Foster, C. S., Jameson, C., Barbachanno, Y., Bartlett, J., Bancroft, E., Doherty, R., Kote-Jarai, Z., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604132 · Cited by 173
Self-citationGenome-wide association study identifies new prostate cancer susceptibility loci
Schumacher, F. R., Berndt, S. I., Siddiq, A., Jacobs, K. B., Wang, Z., Lindstrom, S., Stevens, V. L., Chen, C., Mondul, A. M., Travis, R. C., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr295 · Cited by 171
Self-citationEvidence for two independent prostate cancer risk–associated loci in the HNF1B gene at 17q12
Sun, J., Zheng, S. L., Wiklund, F., Isaacs, S. D., Purcell, L. D., Gao, Z., Hsu, F.-C., Kim, S.-T., Liu, W., Zhu, Y., et al. (2008) · Nature Genetics · doi:10.1038/ng.214 · Cited by 168
Kerns, S. L., D, H. O. M., Stock, R. G., Li, W. H. C., Moore, J. O., Pearlman, A. W., Campbell, C. L., Shao, Y., Stone, N. N., Kusnetz, L., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.07.036 · Cited by 164
Dagnelie, P. C., Schuurman, A. G., Goldbohm, R. A., & Van Den Brandt, P. A. (2004) · BJU International · doi:10.1111/j.1464-410x.2004.04795.x · Cited by 163
Rapid progression of prostate cancer in men with a BRCA2 mutation
the Hereditary Breast Cancer Study Group, Narod, S. A., Neuhausen, S., Vichodez, G., Armel, S., Lynch, H. T., Ghadirian, P., Cummings, S., Olopade, O., Stoppa-Lyonnet, D., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604453 · Cited by 162
Hoxb13 is required for normal differentiation and secretory function of the ventral prostate
Economides, K. D., & Capecchi, M. R. (2003) · Development · doi:10.1242/dev.00432 · Cited by 162
Polygenic susceptibility to prostate and breast cancer: implications for personalised screening
Pashayan, N., Duffy, S. W., Chowdhury, S., Dent, T., Burton, H., Neal, D. E., Easton, D. F., Eeles, R., & Pharoah, P. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.118 · Cited by 161
Self-citationKote-Jarai, Z., Easton, D. F., Stanford, J. L., Ostrander, E. A., Schleutker, J., Ingles, S. A., Schaid, D., Thibodeau, S., Dörk, T., Neal, D., et al. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0317 · Cited by 161
Self-citationHoffmann, T. J., Zhan, Y., Kvale, M. N., Hesselson, S. E., Gollub, J., Iribarren, C., Lu, Y., Mei, G., Purdy, M. M., Quesenberry, C., et al. (2011) · Genomics · doi:10.1016/j.ygeno.2011.08.007 · Cited by 160
Yang, M., Xie, W., Mostaghel, E., Nakabayashi, M., Werner, L., Sun, T., Pomerantz, M., Freedman, M., Ross, R., Regan, M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.2405 · Cited by 159
A Novel Founder CHEK2 Mutation is Associated with Increased Prostate Cancer Risk
Cybulski, C., Huzarski, T., Górski, B., Masojć, B., Mierzejewski, M., Dębniak, T., Gliniewicz, B., Trubicka, J., Złowocka, E., Kurzawski, G., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0341 · Cited by 158
Lindström, S., Schumacher, F. R., Siddiq, A., Travis, R. C., Campa, D., Berndt, S. I., Diver, W. R., Severi, G., Allen, N. E., Andriole, G., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017142 · Cited by 157
Linkage and Association Studies of Prostate Cancer Susceptibility: Evidence for Linkage at 8p22-23
Xu, J., Zheng, S. L., Hawkins, G. A., Faith, D., Kelly, B., Isaacs, S. D., Wiley, K. E., Chang, B., Ewing, C. M., Bujnovszky, P., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/321967 · Cited by 154
A Population-based Assessment of Germline HOXB13 G84E Mutation and Prostate Cancer Risk
Karlsson, R., Aly, M., Clements, M., Zheng, L. S., Adolfsson, J., Xu, J., Grönberg, H., & Wiklund, F. E. (2012) · European Urology · doi:10.1016/j.eururo.2012.07.027 · Cited by 150
Xu, J., Dimitrov, L. M., Chang, B., Adams, T. S., Turner, A. R., Meyers, D. A., Eeles, R. A., Easton, D. F., Foulkes, W. D., Simard, J., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/432377 · Cited by 146
Self-citationEstablishment of a Radiogenomics Consortium
West, C., & Rosenstein, B. S. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.12.017 · Cited by 141
Olama, A. A. A., Kote-Jarai, Z., Schumacher, F. R., Wiklund, F., Berndt, S. I., Benlloch, S., Giles, G. G., Severi, G., Neal, D. E., Hamdy, F. C., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds425 · Cited by 134
Self-citationDiet, lifestyle and risk of prostate cancer
Wolk, A. (2005) · Acta Oncologica · doi:10.1080/02841860510029572 · Cited by 130
Khoury, M. J., Little, J., GWINN, M. L., & Ioannidis, J. P. A. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyl253 · Cited by 129
Akamatsu, S., Takata, R., Haiman, C. A., Takahashi, A., Inoue, T., Kubo, M., Furihata, M., Kamatani, N., Inazawa, J., Chen, G. K., et al. (2012) · Nature Genetics · doi:10.1038/ng.1104 · Cited by 118
Transmission Disequilibrium, Family Controls, and Great Expectations
Schaid, D. J. (1998) · The American Journal of Human Genetics · doi:10.1086/302077 · Cited by 117
Cybulski, C., Wokołorczyk, D., Huzarski, T., Byrski, T., Gronwald, J., Górski, B., Dębniak, T., Masojć, B., Jakubowska, A., Gliniewicz, B., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.044974 · Cited by 115
Where are the prostate cancer genes?—A summary of eight genome wide searches
Easton, D. F., Schaid, D. J., Whittemore, A. S., & Isaacs, W. J. (2003) · The Prostate · doi:10.1002/pros.10300 · Cited by 111
Self-citationCui, J. S., Antoniou, A. C., Dite, G. S., Southey, M. C., Venter, D. J., Easton, D. F., Giles, G. G., McCredie, M. R. E., & Hopper, J. L. (2001) · The American Journal of Human Genetics · doi:10.1086/318187 · Cited by 110
Self-citationGenetic Analysis of the RNASEL Gene in Hereditary, Familial, and Sporadic Prostate Cancer
Wiklund, F. E., Jonsson, B., Brookes, A. J., Strömqvist, L., Adolfsson, J., Emanuelsson, M., Adami, H., Bälter, K. A., & Grönberg, H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0982 · Cited by 107
Kader, A. K., Sun, J., Isaacs, S. D., Wiley, K. E., Yan, G., Kim, S., Fedor, H. L., Marzo, A. M. D., Epstein, J. I., Walsh, P. C., et al. (2009) · The Prostate · doi:10.1002/pros.20970 · Cited by 106
Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript
Kote‐Jarai, Z., Olama, A. A. A., Leongamornlert, D. A., Tymrakiewicz, M., Saunders, E. J., Guy, M., Giles, G. G., Severi, G., Southey, M. C., Hopper, J. L., et al. (2011) · Human Genetics · doi:10.1007/s00439-011-0981-1 · Cited by 99
Self-citationDirect-to-consumer personalized genomic testing
Bloss, C. S., Darst, B. F., Topol, E. J., & Schork, N. J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr349 · Cited by 97
The UKGPCS Collaborators, T. B. A. O. U. S. S. O. O., Kote-Jarai, Z., Jugurnauth, S., Mulholland, S., Leongamornlert, D. A., Guy, M., Edwards, S., Tymrakiewitcz, M., O'Brien, L., Hall, A., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604847 · Cited by 91
Self-citationSusceptibility Loci Associated with Prostate Cancer Progression and Mortality
Gallagher, D. J., Vijai, J., Cronin, A. M., Bhatia, J., Vickers, A. J., Gaudet, M. M., Fine, S. W., Reuter, V. E., Scher, H. I., Halldén, C., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0028 · Cited by 86
Laitinen, V. H., Wahlfors, T., Saaristo, L., Rantapero, T., Pelttari, L. M., Kilpivaara, O., Laasanen, S., Kallioniemi, A. H., Nevanlinna, H. A., Aaltonen, L. A., et al. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1000-t · Cited by 83
Kim, Y.-R., Oh, K. J., Park, R., Xuân, N. T., Kang, T.-W., Kwon, D., Choi, C., Kim, M. S., Kim, K. K., Ahn, K. Y., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-124 · Cited by 83
Association of theCYP1B1*3allele with survival in patients with prostate cancer receiving docetaxel
Sissung, T. M., Danesi, R., Price, D. K., Steinberg, S. M., de Wit, R., Zahid, M., Gaikwad, N. W., Cavalieri, E. L., Dahut, W. L., Sackett, D. L., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0557 · Cited by 82
Xu, J., Gillanders, E. M., Isaacs, S. D., Chang, B., Wiley, K. E., Zheng, S. L., Jones, M., Gildea, D. E., Riedesel, E. L., Albertus, J. A., et al. (2003) · The Prostate · doi:10.1002/pros.10306 · Cited by 80
Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene
Maier, C., Haeusler, J., Herkommer, K., Vesovic, Z., Hoegel, J. J., Vogel, W., & Paiss, T. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602401 · Cited by 79
The potential value of microseminoprotein‐β as a prostate cancer biomarker and therapeutic target
Whitaker, H. C., Warren, A. Y., Eeles, R. A., Kote‐Jarai, Z., & Neal, D. E. (2009) · The Prostate · doi:10.1002/pros.21059 · Cited by 78
Self-citationMacInnis, R. J., Antoniou, A. C., Eeles, R. A., Severi, G., Olama, A. A. A., McGuffog, L., Kote‐Jarai, Z., Guy, M., O'Brien, L. T., Hall, A. L., et al. (2011) · Genetic Epidemiology · doi:10.1002/gepi.20605 · Cited by 77
Self-citationHuang, S., Huang, L., Ting, W., Chen, L., Chang, T.-Y., Lu, T., Lan, Y., Liu, C., Yang, W., Lee, H., et al. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0665 · Cited by 76
Prostate-Cancer Screening — What the U.S. Preventive Services Task Force Left Out
Brett, A. S., & Ablin, R. J. (2011) · New England Journal of Medicine · doi:10.1056/nejmp1112191 · Cited by 73
Wiklund, F. E., Gillanders, E. M., Albertus, J. A., Bergh, A. R. J., Damber, J., Emanuelsson, M., Freas‐Lutz, D., Gildea, D. E., Göransson, I., Jones, M., et al. (2003) · The Prostate · doi:10.1002/pros.10303 · Cited by 72
Sandhu, S. K., Omlin, A. G., Hylands, L., Miranda, S., Barber, L. J., Riisnaes, R., Reid, A. H. M., Attard, G., Chen, L., Kozarewa, I., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt074 · Cited by 69
Kerns, S. L., Stock, R. G., Stone, N. N., Buckstein, M. H., Shao, Y., Campbell, C. L., Rath, L., Ruysscher, D. D., Lammering, G., Hixson, R. D., et al. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.08.003 · Cited by 66
Genomic scan of 254 hereditary prostate cancer families
Janer, M., Friedrichsen, D. M., Stanford, J. L., Badzioch, M. D., Kolb, S., Deutsch, K., Peters, M. A., Goode, E. L., Welti, R., DeFrance, H. B., et al. (2003) · The Prostate · doi:10.1002/pros.10305 · Cited by 63
Association of Prostate Cancer Risk Variants with Clinicopathologic Characteristics of the Disease
Xu, J., Isaacs, S. D., Sun, J., Li, G., Wiley, K. E., Zhu, Y., Hsu, F., Wiklund, F. E., Turner, A. R., Adams, T. S., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0934 · Cited by 62
A Multicenter Study of Cancer Incidence in CHEK2 1100delC Mutation Carriers
Thompson, D. J., Seal, S., Schutte, M. E. M., McGuffog, L., Barfoot, R., Renwick, A., Eeles, R. A., Sodha, N., Houlston, R. S., Shanley, S., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0687 · Cited by 61
Self-citationSun, J., Wiklund, F. E., Hsu, F., Bälter, K. A., Zheng, S., Johansson, J., Chang, B., Liu, W., Li, T., Turner, A. R., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0645 · Cited by 59
Kerns, S. L., Stone, N. N., Stock, R. G., Rath, L., D, H. O. M., & Rosenstein, B. S. (2013) · The Journal of Urology · doi:10.1016/j.juro.2013.01.096 · Cited by 57
Genetic Alterations of Androgen Receptor Gene in Japanese Human Prostate Cancer
Watanabe, M., Ushijima, T., Shiraishi, T., Yatani, R., Shimazaki, J., Kotake, T., Sugimura, T., & Nagao, M. (1997) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/27.6.389 · Cited by 56
Huang, C., Huang, S., Pao, J.-B., Chang, T.-Y., Lan, Y. ‐., Lu, T., Lee, H.-Z., Juang, S., Wu, P., Pu, Y., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr264 · Cited by 56
Prostate Cancer Susceptibility Variants Confer Increased Risk of Disease Progression
Cheng, I. C., Plummer, S. J., Neslund-Dudas, C. M., Klein, E. A., Casey, G., Rybicki, B. A., & Witte, J. S. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0268 · Cited by 55
Dluzniewski, P. J., Wang, M., Zheng, S. L., Marzo, A. M. D., Drake, C. G., Fedor, H. L., Partin, A. W., Han, M., Fallin, M. D., Xu, J., et al. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0458 · Cited by 55
Schleutker, J., Baffoe‐Bonnie, A. B., Gillanders, E. M., Kainu, T., Jones, M. S., Freas‐Lutz, D., Markey, C. J., Gildea, D. E., Riedesel, E. L., Albertus, J. A., et al. (2003) · The Prostate · doi:10.1002/pros.10302 · Cited by 53
Utility of Incorporating Genetic Variants for the Early Detection of Prostate Cancer
Nam, R. K., Zhang, W., Trachtenberg, J., Seth, A. K., Klotz, L. H., Stanimirovic, A., Punnen, S., Venkateswaran, V., Toi, A., Loblaw, D. A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1593 · Cited by 53
Cunningham, J. M., McDonnell, S. K., Marks, A. F., Hebbring, S. J., Anderson, S. A., Peterson, B. J., Slager, S. L., French, A. J., Blute, M. L., Schaid, D. J., et al. (2003) · The Prostate · doi:10.1002/pros.10308 · Cited by 53
Association of Megalin Genetic Polymorphisms with Prostate Cancer Risk and Prognosis
Holt, S. K., Karyadi, D. M., Kwon, E. M., Stanford, J. L., Nelson, P. S., & Ostrander, E. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4566 · Cited by 50
Role of the Nijmegen Breakage Syndrome 1 Gene in Familial and Sporadic Prostate Cancer
Hebbring, S. J., Fredriksson, H., White, K. A., Maier, C., Ewing, C. M., McDonnell, S. K., Jacobsen, S. J., Cerhan, J. R., Schaid, D. J., Ikonen, T., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0910 · Cited by 49
Evidence for a Prostate Cancer Susceptibility Locus on the X Chromosome
Xu, J., Meyers, D. A., Freije, D., Isaacs, S. D., Wiley, K. E., Nusskern, D. R., Ewing, C. M., Wilkens, E. P., Bujnovszky, P., Bova, G. S., et al. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(01)61689-6 · Cited by 46
Analysis of the gene coding for the BRCA2‐Interacting protein PALB2 in hereditary prostate cancer
Tischkowitz, M. D., Sabbaghian, N., Ray, A. M., Lange, E. M., Foulkes, W. D., & Cooney, K. A. (2008) · The Prostate · doi:10.1002/pros.20729 · Cited by 41
Goh, C. L., Saunders, E. J., Leongamornlert, D. A., Tymrakiewicz, M., Thomas, K., Selvadurai, E. D., Woode‐Amissah, R., Dadaev, T., Mahmud, N., Castro, E., et al. (2013) · British Journal of Urology · doi:10.1111/j.1464-410x.2012.11648.x · Cited by 40
Self-citationMarugame, T., & Katanoda, K. (2006) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyl049 · Cited by 40
Whitman, E. J., Pomerantz, M. M., Chen, Y., Chamberlin, M. M., Furusato, B., Gao, C., Ali, A., Ravindranath, L., Dobi, A., Sestrehenn, I. A., et al. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-1111 · Cited by 39
Schaid, D. J., & Chang, B. (2004) · The Prostate · doi:10.1002/pros.20198 · Cited by 36
Helfand, B. T., Loeb, S., Cashy, J., Meeks, J. J., Thaxton, C. S., Han, M., & Catàlona, W. J. (2008) · The Journal of Urology · doi:10.1016/j.juro.2008.01.110 · Cited by 36
Lange, E. M., Robbins, C. M., Gillanders, E. M., Zheng, S. L., Xu, J., Wang, Y., White, K. A., Chang, B., Ho, L. A., Trent, J. M., et al. (2006) · Human Genetics · doi:10.1007/s00439-006-0274-2 · Cited by 34
Cussenot, O., Azzouzi, A.-R., Bantsimba-Malanda, G., Gaffory, C., Mangin, P., Cormier, L., Fournier, G., Valéri, A., Jouffe, L., Morgan Rouprêt, A., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4999 · Cited by 34
MacInnis, R. J., Antoniou, A. C., Eeles, R. A., Severi, G., Guy, M., McGuffog, L., Hall, A. L., O'Brien, L. T., Wilkinson, R. A., Dearnaley, D. P., et al. (2009) · Genetic Epidemiology · doi:10.1002/gepi.20433 · Cited by 33
Self-citationFitzGerald, L. M., Patterson, B., Thomson, R. J., Polanowski, A. M., Quinn, S. J., Brohede, J., Thornton, T. A., Challis, D. R., Mackey, D. A., Dwyer, T., et al. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.171 · Cited by 31
Screening of genetic and expression alterations of SRC1 gene in prostate cancer
Mäki, H. E., Waltering, K. K., Wallén, M. J., MARTIKAINEN, P. M., Tammela, T. L. J., van Weerden, W. M., Vessella, R. L., & Visakorpi, T. (2006) · The Prostate · doi:10.1002/pros.20427 · Cited by 31
Inherited Variation in Hormone-Regulating Genes and Prostate Cancer Survival
Lindström, S., Adami, H., Bälter, K. A., Xu, J., Zheng, S. L., Stattin, P. E., Grönberg, H., & Wiklund, F. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0669 · Cited by 28
Macrophage Scavenger Receptor 1 999C>T (R293X) Mutation and Risk of Prostate Cancer
Hope, Q., Bullock, S. L., Evans, C., Meitz-Hopkins, J. C., Hamel, N., Edwards, S. M., Severi, G., Dearnaley, D. P., Jhavar, S. G., Southgate, C., et al. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0202 · Cited by 21
Self-citationJin, G., Lu, L., Cooney, K. A., Ray, A. M., Zuhlke, K. A., Lange, E. M., Cannon‐Albright, L., Camp, N. J., Teerlink, C. C., FitzGerald, L. M., et al. (2011) · Human Genetics · doi:10.1007/s00439-011-1136-0 · Cited by 21
Self-citationNarita, S., Tsuchiya, N., Yuasa, T., Maita, S., Obara, T., Numakura, K., Tsuruta, H., Saito, M., Inoue, T., Horikawa, Y., et al. (2011) · International Journal of Clinical Oncology · doi:10.1007/s10147-011-0275-6 · Cited by 20
Helfand, B. T., Kan, D., Modi, P. K., & Catàlona, W. J. (2010) · The Prostate · doi:10.1002/pros.21253 · Cited by 17
Pathological Aggressiveness of Prostatic Carcinomas Related to RNASEL R462Q Allelic Variants
Larson, B. T., Magi‐Galluzzi, C., Casey, G., Plummer, S. J., Silverman, R. H., & Klein, E. A. (2008) · The Journal of Urology · doi:10.1016/j.juro.2007.11.078 · Cited by 16
Genetic counseling for prostate cancer risk
Nieder, A., Taneja, S., Zeegers, M. P. A., & D, H. O. M. (2003) · Clinical Genetics · doi:10.1034/j.1399-0004.2003.00038.x · Cited by 15
Lu, L., Cancel‐Tassin, G., Valéri, A., Cussenot, O., Lange, E. M., Cooney, K. A., Farnham, J. M., Camp, N. J., Cannon‐Albright, L., Tammela, T. L. J., et al. (2011) · The Prostate · doi:10.1002/pros.21443 · Cited by 14
Self-citationLange, E. M. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0449-2_7 · Cited by 9
FitzGerald, L. M., McDonnell, S. K., Carlson, E. E., Langeberg, W. J., McIntosh, L. M., Deutsch, K., Ostrander, E. A., Schaid, D. J., & Stanford, J. L. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.49 · Cited by 7
Bailey‐Wilson, J. E., Childs, E. J., Cropp, C. D., et al. (2012) · BMC Medical Genetics · doi:10.1186/1471-2350-13-46 · Cited by 6
Cited by
The personal and clinical utility of polygenic risk scores
Torkamani, A., Wineinger, N. E., & Topol, E. J. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0018-x · Cited by 1,623
Attard, G., Parker, C., Eeles, R. A., Schröder, F., Tomlins, S. A., Tannock, I., Drake, C. G., & de Bono, J. S. (2016) · The Lancet · doi:10.1016/s0140-6736(14)61947-4 · Cited by 905
Self-citationAssociation analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Study, T. P., Schumacher, F. R., (APCB), A. P. C. B., Study, T. I., Canary PASS Investigators, Breast and Prostate Cancer Cohort Consortium (BPC3), The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, (CAPS), C. O. T. P. I. S., Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS), The Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium, et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0142-8 · Cited by 902
Self-citationGenetics and biology of prostate cancer
Wang, G., Zhao, D., Spring, D. J., & DePinho, R. A. (2018) · Genes & Development · doi:10.1101/gad.315739.118 · Cited by 750
Sandhu, S., Moore, C. M., Chiong, E., Beltran, H., Bristow, R. G., & Williams, S. G. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00950-8 · Cited by 583
Metadata
- Authors
- Eeles, R., Goh, C., Castro, E., Bancroft, E., Guy, M., Olama, A. A. A., Easton, D., & Kote-Jarai, Z.
- Venue
- Nature Reviews Urology
- Published
- 2013-12-03
- Volume
- 11
- Issue
- 1
- Pages
- 18-31
- ISSN
- 1759-4812 (ISSN-L)
- 1759-4820
- OpenAlex
- W2087345933
- Cited by
- 260
- References
- 141
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.